about
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodiesAnti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE?Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience.Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis.Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome).Neuroimmunopathology in a murine model of neuropsychiatric lupusVon Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus.Comparison of the clinical manifestations, brain MRI and prognosis between neuroBeçhet's disease and neuropsychiatric lupus.Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome.Losing your nerves? Maybe it's the antibodies.Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers.Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.The antiphospholipid syndrome: from pathophysiology to treatment.Colour Doppler ultrasound of the ocular circulation in patients with systemic lupus erythematosus identifies altered microcirculatory haemodynamics.Improvement of irregularity of brain vessel walls in systemic lupus erythematosus by tacrolimus.Cranial nerve palsies: sarcoidosis to systemic lupus erythematosus.Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.Neuropsychological development of children born to patients with systemic lupus erythematosus.
P2860
Q24805595-501C4031-FC68-46DE-BAA5-A252A848010EQ33251075-84C4D990-C224-46B0-BF79-2ECF02122AA8Q33292539-25C07451-94B9-4C20-8220-6646E41FEC36Q34075832-515F1FA2-1804-4602-BB0B-574BE0C5EA8CQ34787911-68314CFA-4ECF-40E9-B9FB-9BAF528A0479Q34896821-D9324777-117C-40E3-8AD1-D5D7E38512C0Q35555433-AD28FF34-7AAC-4D5F-ABC8-B1537DCBA52FQ35849691-88A9AA15-1A04-47D8-AEEE-99A77D815DC9Q36458150-9D177B36-19CE-4F13-AD39-EEE24BAE70D4Q36707992-91CDD9D4-61D8-423B-86BD-55B273D8B459Q36908457-2726EB3A-9AD3-42F3-B004-FBE5AC4004BDQ37205229-58BA1FFD-6C33-42F2-8090-5D0B2B8CE756Q37283036-38D3F98D-0860-4E03-90AF-DB690BD2FA09Q37440005-6057BFAB-7582-43F1-B79E-9E8F06EF06ECQ37556128-246C67D1-AD94-4F53-9AA9-B2CBF21CC737Q38237868-84C7247C-AB37-485C-A687-806FB2226B1DQ38844621-EC0D44F4-5260-4650-B0E6-0327775778DCQ38873953-75AEC33B-7B82-4664-BEAD-38FF05CC8F02Q39946264-D523F2F1-B23A-49D2-B3D1-2CA80D776B9CQ40344419-EE0B5141-D24D-4581-BEA9-E3BD1C2F6B1CQ43164302-DF569C58-3B2A-4911-9636-D3FEA75CD93AQ44106531-8CE6A530-20DA-4FB2-A891-BD5265B584DFQ52085774-D74A69E5-8078-4B94-8602-725D8665A513
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Endothelium and the brain in CNS lupus.
@ast
Endothelium and the brain in CNS lupus.
@en
type
label
Endothelium and the brain in CNS lupus.
@ast
Endothelium and the brain in CNS lupus.
@en
prefLabel
Endothelium and the brain in CNS lupus.
@ast
Endothelium and the brain in CNS lupus.
@en
P2093
P2860
P1433
P1476
Endothelium and the brain in CNS lupus.
@en
P2093
A Salmaggi
I Cavazzana
S Pellegrini
P2860
P304
P356
10.1191/0961203303LU503OA
P577
2003-01-01T00:00:00Z